Skip to content

Comprehensive Imaging of Perforator Vessels and Subcutaneous Vascular Network With No-Exogenous Contrast and Non-Ionizing-Radiation Magnetic Resonance Angiography

Comprehensive Imaging of Perforator Vessels and Subcutaneous Vascular Network With No-Exogenous Contrast and Non-Ionizing-Radiation Magnetic Resonance Angiography

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03567018
Enrollment
23
Registered
2018-06-25
Start date
2012-07-02
Completion date
2024-12-31
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perforator Flap Surgery

Brief summary

In this study the investigators plan to enroll a total of 25 evaluable volunteers (volunteer population) for the development and optimization of perforator imaging protocols and 50 evaluable clinical patients receiving flap procedures at OSUMC for the clinical validation of the optimized protocol. No extrinsic MR contrast agent will be injected. Clinical patients' MRI images will be evaluated independently by radiologists and plastic surgeons and compared to the clinical CTA images.

Detailed description

The overall objective of this pilot study is to develop and optimize preoperative MRA imaging protocols for various perforators commonly used in flap surgery with phantoms and healthy volunteers and to obtain clinical validation of the optimized protocols with a group of patients receiving flap surgery at The OSU Wexmer Medical Center. Data obtained in this study may also serve as the basis for statistical planning of future clinical trials. Based on previous experience with other magnetic resonance imaging (MRI) techniques, the investigators hypothesize that optimal MRA images can only be obtained with a carefully selected combination of imaging hardware, acquisition, and postprocessing factors. The main objective of this pilot study is to determine this optimal combination through the comparison of image between different combinations. The secondary objective of this pilot study is to evaluate, both qualitatively and quantitatively, the quality of the optimized MRA images and compare them with clinical CTA images. The primary hypothesis is that the quality of the optimized MRA images is at least comparable to that of the CTA images. The quantitative measurements obtained from this pilot population will also serve as the preliminary data for future studies and be used in statistical calculations that determine their study population.

Interventions

DEVICEMRI Scan

Study participants will be scanned with a 3.0 Tesla Phillips Ingenia CX whole body clinical MRI system located at the Wright Center of Innovation at The Ohio State University Medical Center. Anatomical and angiographic MR images will be acquired for one of the most commonly used flap surgery donor perforators including but not limited to: the deep inferior epigastric perforators (DIEP); the superior gluteal arter perforators (SGAP); the inferior gluteal artery perforators (IGAP); the thoracodorsal artery perforators (TDAP); the anterolateral thigh perforators (ATL).

Sponsors

Wright Center of Innovation in Biomedical Imaging
CollaboratorUNKNOWN
University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Two populations are being investigated in this trial; a healthy volunteer population and a patient population. Each population will receive an MRI scan.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* greater than or equal to 18 years at time of enrollment * able to provide informed consent * able to lie in both prone and supine positions for at least 30 minutes * the clinical patients need to have a flap procedure scheduled at the Ohio State University Medical Center within the next 24 months

Exclusion criteria

* Use of an IUD (intrauterine device) or medical patch * Subjects with any type of activatable implants (e.g. cardiac pacemakers, deep brain stimulators, spinal cord stimulators, cochlear implants, electronic infusion pumps, etc.) * Subjects with any type of metallic implants or foreign objects in torso region (e.g. cardiac stents, surgical clips, shrapnel fragments from war wounds, etc.) * metal works and machinists (who may have metallic fragments in or near the eyes) * severe auto accident victims * subjects with permanent tattoos that may contain metallic coloring * subjects with previous history of perforator flap surgery * subjects who cannot communicate with the researcher for any reason * claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
image qualitythrough study completion, on average 2-5 yearsassessed by blinded readers
Artifacts in MRI images assessed by experienced readersthrough study completion, on average 2-5 yearsassessed by blinded readers
Vessel detectability in MRI assessed by experienced readersthrough study completion, on average 2-5 yearsassessed by blinded readers
Image noise as a measure of image quality assessed by quantitative measuresthrough study completion, on average 2-5 yearsassessed region of interest over target tissue and background

Secondary

MeasureTime frameDescription
Signal-to-noise ratio (SNR)BaselineROI based assessment
Contrast-to-noise ratio (CNR) to muscle and fatBaselineROI based assessment
Anatomy accuracy60 minLocation on images
Length of perforator intramuscular course60 minLocation on images
Perforator size60 minLocation on images
Vascular network continuity60 minLocation on images
Perforator branching pattern60 minLocation on images
Potential Clinical Use of the MRI Images for Clinical Decision makingBaselineClinical reader assessment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026